Hematopoietic Stem Cell TransplantationSpleenThymus GlandTransplantation, HomologousStem Cell TransplantationTransplantation, AutologousLiver TransplantationTransplantation ConditioningBone Marrow TransplantationPeripheral Blood Stem Cell TransplantationGraft vs Host DiseaseKidney TransplantationCell TransplantationGraft SurvivalHeart TransplantationHematologic NeoplasmsTransplantation ChimeraTissue DonorsLung TransplantationTreatment OutcomeCord Blood Stem Cell TransplantationTransplantation ImmunologyT-LymphocytesGraft RejectionImmunosuppressive AgentsOrgan TransplantationImmunosuppressionIslets of Langerhans TransplantationWhole-Body IrradiationHistocompatibility TestingTransplantation, IsogeneicMyeloablative AgonistsHistocompatibilityMice, Inbred BALB CTime FactorsMice, Inbred C57BLTransplantationRetrospective StudiesRecurrenceMesenchymal Stem Cell TransplantationPancreas TransplantationBusulfanMice, Inbred StrainsAntilymphocyte SerumCombined Modality TherapyLymphocyte TransfusionMultiple MyelomaRemission InductionAntibody FormationLymphocytesMelphalanSurvival AnalysisCyclophosphamideLiving DonorsSurvival RateLeukemiaGraft vs Leukemia EffectTransplantation ToleranceVidarabineThymectomyHemolytic Plaque TechniqueLymphocyte ActivationCells, CulturedDisease-Free SurvivalHLA AntigensImmune ToleranceFollow-Up StudiesConcanavalin AHematopoietic Stem CellsTransplantation, HeterotopicLymphocyte DepletionB-LymphocytesMice, Inbred C3HFetal Tissue TransplantationChimerismAntibodies, MonoclonalBone Marrow CellsGraft vs Tumor EffectGraft vs Host ReactionMice, Inbred CBAImmunization, PassiveCyclosporineLeukemia, Myeloid, AcuteHeart-Lung TransplantationUnrelated DonorsBone MarrowThymus NeoplasmsTransplantation, HeterologousHepatic Veno-Occlusive DiseaseTissue and Organ ProcurementCell DifferentiationAntineoplastic Combined Chemotherapy ProtocolsImmunity, CellularSiblingsHematopoietic Stem Cell MobilizationAntibody-Producing CellsSalvage TherapyAcute DiseaseCytomegalovirus InfectionsHematologic Diseases